Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury

<table>Schematic representation of the perfusion protocol for isolated cardiomyocytes. Scrambled siRNA was used as a control of MMP-2 siRNA. Arrows indicate when cell contractility was measured: (1) before siRNA transfection, (2) before ischemia, and (3) at the end of reperfusion.</table>

BioMed Research International

fig1

Figure 1

Figure 1: Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury 

Figure 1 | Inhibition of MMP-2 Expression with siRNA Increases Baseline Cardiomyocyte Contractility and Protects against Simulated Ischemic Reperfusion Injury 